This suggests that gut bacteria-dependent bile acid deconjugation in Ob/ob mice activates FXR activity and inhibit the FXR-small heterodimer partner (SHP) signaling pathway leading to increased fat biosynthesis and nonalcoholic hepatic steatosis. The gene discussed is NR0B2; the disease is Hepatic steatosis.